Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05011513 |
|---|---|
| Brief Title: | Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR). |
| First Submitted : | July 30, 2021 |
| First Submitted that Met QC Criteria : | August 16, 2021 |
| First Posted : | August 18, 2021 |
| Last Update Submitted that Met QC Criteria : | December 9, 2022 |
| Last Update Posted : | December 12, 2022 |